Bahadoran Ensiyeh, Rahmani Babak, Nazari Esfandiyar, Hosseinnezhad Aida, Samieerad Fatemeh
Cellular and Molecular Research Center, Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Iran J Pathol. 2025;20(1):108-117. doi: 10.30699/ijp.2024.2036312.3330. Epub 2025 Jan 10.
BACKGROUND & OBJECTIVE: Human papillomavirus (HPV) is a major cause of cervical cancer and mortality, particularly in low-income countries. Late diagnosis of cervical cancer often leads to advanced-stage disease, resulting in poorer prognosis and higher mortality, which underscores the critical need for effective early screening methods. Pap smears, colposcopy, and HPV testing are essential for early detection. This study addresses a gap in the literature by comparing the effectiveness of different diagnostic methods specifically in women with multiple high-risk HPV (hrHPV) infections-a population for which limited comparative data exist.
This prospective cross-sectional study, approved by the Ethical Committee of Qazvin University (IR.QUMS.REC.1400.143), was conducted at Kowsar Hospital from 2022 to 2023 and included 608 patients infected with multiple hrHPV subtypes. Inclusion criteria required hrHPV confirmation by PCR genotyping and excluded patients without colposcopy and biopsy or with a history of cervical dysplasia. Participants underwent Pap smear cytology, colposcopy, and biopsy, with the biopsy specimens examined by a gynecologic pathologist. Statistical analyses included chi-square tests for qualitative variables and t-tests or ANOVA for quantitative variables, with a significance level set at P<0.05.
The average age of the patients was 38.54 years, with the majority aged 30-39 years (43.6%). Common symptoms included vaginal discharge (36.5%) and postcoital bleeding (34.9%). Pap smear results showed ASCUS in 43.6% of cases and LSIL in 39.1%. Colposcopy revealed acetowhite lesions in 45.6% and abnormal vascular patterns in 25.5%. Histopathology indicated that 72.4% of patients had CIN I. Smoking was significantly correlated with colposcopic findings (P=0.044). Colposcopy demonstrated the highest sensitivity (69.1%) for detecting cervical lesions, while cytology had the highest specificity (63.1%).
Pap smear findings provide adequate diagnostic accuracy for hrHPV patients, but colposcopy offers superior sensitivity for detecting cervical lesions. Combining both methods is recommended to improve diagnosis.
人乳头瘤病毒(HPV)是宫颈癌及相关死亡的主要原因,在低收入国家尤为如此。宫颈癌的晚期诊断常导致疾病处于晚期,预后较差且死亡率较高,这凸显了有效早期筛查方法的迫切需求。巴氏涂片、阴道镜检查和HPV检测对于早期发现至关重要。本研究通过比较不同诊断方法在多重高危型HPV(hrHPV)感染女性中的有效性,填补了文献中的空白,对于这一人群,现有的比较数据有限。
这项前瞻性横断面研究经加兹温大学伦理委员会批准(IR.QUMS.REC.1400.143),于2022年至2023年在科萨尔医院进行,纳入了608例感染多种hrHPV亚型的患者。纳入标准要求通过PCR基因分型确认hrHPV感染,排除未进行阴道镜检查和活检或有宫颈发育异常病史的患者。参与者接受了巴氏涂片细胞学检查、阴道镜检查和活检,活检标本由妇科病理学家检查。统计分析包括定性变量的卡方检验和定量变量的t检验或方差分析,显著性水平设定为P<0.05。
患者的平均年龄为38.54岁,大多数年龄在30 - 39岁(43.6%)。常见症状包括阴道分泌物增多(36.5%)和性交后出血(34.9%)。巴氏涂片结果显示43.6%的病例为意义不明确的非典型鳞状细胞(ASCUS),39.1%为低度鳞状上皮内病变(LSIL)。阴道镜检查发现45.6%有醋酸白色病变,25.5%有异常血管形态。组织病理学显示72.4%的患者有宫颈上皮内瘤变I级(CIN I)。吸烟与阴道镜检查结果显著相关(P = 0.044)。阴道镜检查对检测宫颈病变的敏感性最高(69.1%),而细胞学检查的特异性最高(63.1%)。
巴氏涂片检查结果对hrHPV感染患者具有足够的诊断准确性,但阴道镜检查对检测宫颈病变具有更高的敏感性。建议联合使用这两种方法以提高诊断效果。